ClinicalTrials.Veeva

Menu

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

S

St George's Healthcare NHS Trust

Status

Unknown

Conditions

Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT01154998
10/H1102/46

Details and patient eligibility

About

There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.

Enrollment

360 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • idiopathic fibrotic lung disease

Exclusion criteria

  • non idiopathic fibrotic lung disease

Trial design

360 participants in 2 patient groups

Cases
Controls

Trial contacts and locations

1

Loading...

Central trial contact

Felix Chua, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems